Example of a Burkitt lymphoma treatment programme in Malawi*
| Sensitivity analysis | |||
|---|---|---|---|
| 3% Discounting | 6% Discounting | 0% Discounting† | |
| Years of life lost without treatment | 33.02 | 20.36 | 45.33 |
| Years lived with disability without treatment | 0.01 | 0.01 | 0.01 |
| Years lived with disability during treatment | 0.01 | 0.01 | 0.01 |
| DALYs lost per untreated case, years | 32.97 | 20.28 | 45.16 |
| National DALYs with no treatment, years | 14 773.29 | 9107.39 | 20 278.26 |
| National DALYs averted with treatment, years | 7078.81 | 4359.22 | 9719.44 |
| Upper limit of cost effective, US$/case | $42 729 | $26 313 | $58 669 |
| Upper limit of very cost effective, US$/case | $14 243 | $8771 | $19 556 |
*If results from the included sample study were replicated at the national level.
†No age weight was applied as well.
DALYs, disability-adjusted life years; YLD, years lived with disability.